Search

everythinglearnresearchcommunity

for

Search:↓

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Hair loss requires customized treatments based on its various causes and types.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.

Teletrichoscopy is a promising method for diagnosing hair disorders remotely during the COVID-19 pandemic.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

6.1% of patients seeking PRP for hair loss had undiagnosed cicatricial alopecia, which PRP cannot treat.

An AI photographic device effectively tracked hair growth improvements in women treated for hair loss.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

Male-pattern hair loss is normal, often involves hormone effects on hair follicles, and can be treated with medication or surgery, but new treatments are being researched.

Trichoscopy is a useful, non-invasive way to diagnose different types of hair loss.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.

Tight hairstyles, especially on chemically treated hair, can cause reversible hair loss if caught early but may become permanent if not addressed.

Dermoscopy helps dermatologists diagnose different types of hair loss accurately without always needing a biopsy.

Use trichoscopy to diagnose hair loss; treat with minoxidil, finasteride, or dutasteride; consider platelet-rich plasma and spironolactone.

Erdr1 could be a new marker for diagnosing hair loss.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

The document concludes that identifying the cause of eyebrow and eyelash loss is key to treating it and improving quality of life.

Videodermoscopy improves diagnosis of hair and scalp disorders and may reduce scalp biopsies.

Dermatoscopy and videodermatoscopy are useful for diagnosing and monitoring various skin, hair, and nail conditions.